Skip to main content

Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Dietrich J, Doherty TM. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development. APMIS 2009; 117: 440–57.

Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), remains a major worldwide health problem that causes more than 2 million deaths annually. In addition, an estimated 2 billion people are latently infected with M. tuberculosis. The bacterium is one of the oldest human pathogens and has evolved complex strategies for survival. Therefore, to be successful in the high endemic regions, any future TB vaccine strategy will have to be tailored in accordance with the resulting complexity of the TB infection and anti-mycobacterial immune response. In this review, we will discuss what is presently known about the interaction of M. tuberculosis with the immune system, and how this knowledge is used in new and more advanced vaccine strategies.

Keywords: BCG; Tuberculosis; bacterial; latency; vaccination

Document Type: Research Article

DOI: https://doi.org/10.1111/j.1600-0463.2009.02458.x

Affiliations: Department of Infectious Disease Immunology, Statens Serum Institute, Copenhagen, Denmark

Publication date: 2009-05-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more